Cargando…
Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis
Organising pneumonia (OP) is a form of interstitial pneumonia characterised by inflammation and scarring leading to obstruction within the small airways and alveoli. Practice guidelines recommend treatment of moderate to severe OP with glucocorticoids; however, there have been cases of steroid-resis...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628664/ https://www.ncbi.nlm.nih.gov/pubmed/36319035 http://dx.doi.org/10.1136/bcr-2022-249912 |
_version_ | 1784823235741745152 |
---|---|
author | Loftis, Christine Elizabeth Dulgheru, Emilia Kaplan, Adolfo |
author_facet | Loftis, Christine Elizabeth Dulgheru, Emilia Kaplan, Adolfo |
author_sort | Loftis, Christine Elizabeth |
collection | PubMed |
description | Organising pneumonia (OP) is a form of interstitial pneumonia characterised by inflammation and scarring leading to obstruction within the small airways and alveoli. Practice guidelines recommend treatment of moderate to severe OP with glucocorticoids; however, there have been cases of steroid-resistant OP successfully treated with rituximab. We describe a case of a woman in her 20s with rheumatoid arthritis who presented with pleuritic chest pain, haemoptysis and dyspnoea on exertion and was diagnosed with OP after multiple radiographic images and biopsies. The patient failed numerous treatment regimens, including corticosteroids, antibiotics and mycophenolate, but was successfully treated with rituximab. This case highlights the importance of identifying new therapeutic agents that will minimise the use of glucocorticoids in the treatment of OP. |
format | Online Article Text |
id | pubmed-9628664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-96286642022-11-03 Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis Loftis, Christine Elizabeth Dulgheru, Emilia Kaplan, Adolfo BMJ Case Rep Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation) Organising pneumonia (OP) is a form of interstitial pneumonia characterised by inflammation and scarring leading to obstruction within the small airways and alveoli. Practice guidelines recommend treatment of moderate to severe OP with glucocorticoids; however, there have been cases of steroid-resistant OP successfully treated with rituximab. We describe a case of a woman in her 20s with rheumatoid arthritis who presented with pleuritic chest pain, haemoptysis and dyspnoea on exertion and was diagnosed with OP after multiple radiographic images and biopsies. The patient failed numerous treatment regimens, including corticosteroids, antibiotics and mycophenolate, but was successfully treated with rituximab. This case highlights the importance of identifying new therapeutic agents that will minimise the use of glucocorticoids in the treatment of OP. BMJ Publishing Group 2022-11-01 /pmc/articles/PMC9628664/ /pubmed/36319035 http://dx.doi.org/10.1136/bcr-2022-249912 Text en © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation) Loftis, Christine Elizabeth Dulgheru, Emilia Kaplan, Adolfo Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis |
title | Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis |
title_full | Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis |
title_fullStr | Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis |
title_full_unstemmed | Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis |
title_short | Rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis |
title_sort | rituximab for steroid-resistant organising pneumonia in a woman with rheumatoid arthritis |
topic | Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628664/ https://www.ncbi.nlm.nih.gov/pubmed/36319035 http://dx.doi.org/10.1136/bcr-2022-249912 |
work_keys_str_mv | AT loftischristineelizabeth rituximabforsteroidresistantorganisingpneumoniainawomanwithrheumatoidarthritis AT dulgheruemilia rituximabforsteroidresistantorganisingpneumoniainawomanwithrheumatoidarthritis AT kaplanadolfo rituximabforsteroidresistantorganisingpneumoniainawomanwithrheumatoidarthritis |